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ORIGINAL RESEARCH ARTICLE 
THE EFFECT OF NANOSILVER AND CHLORHEXIDINE MOUTHWASH ON ANAEROBIC 
PERIODONTAL PATHOGENS COUNTS 
ABSTRACT 
The necessitate for frequent application of Chlorhexidine (CHX), and other side effects has encouraged the search 
for option that are more suitable for patients as nanosilver mouthwash (NS). So the aim of this study was to 
determine the effects of a mouthwash made with nanosilver on dental plaque microbial counts and compare it with 
commercially available Chlorhexidine .   Sixty-two plaque-induced gingivitis patients were allocated into two 
groups and asked to rinse with 10 ml of NS and CHX, immediately after brushing, for 1 min, in the morning and 
evening. Sub gingival plaque microbial counts were taken at baseline, two weeks, and finally at four weeks for each 
patient. Subsequently, the samples were collected, transferred and cultured in blood agar in anaerobic media. The 
colonies were counted and expressed as CFUs. The statistical analysis between CFUs variables within groups was 
calculated and the variation significance was calculated by performed t-test.  It is very obvious that the values of 
CFU decreased significantly (p<0.001) as the time of use nanosilver until reaching the highest value when the time 
of use was 4 weeks [70.3±47 to 32.4±24.6 (2 weeks), and 14.2±9.9 (4 weeks) with inhibition of growth rate after 2 
weeks was 46% and after 4 weeks was 79.7%. The effect of commercially available CHX mouthwash was 
approximately similar to the effect of  NS mouthwash used. In conclusion, both Group I and Group II showed 
similar effect on inhibition anaerobic periodontal pathogens counts and gingival health. There was significant 
inhibitory effect on microbial counts where NS mouth-wash had shown better results than CHX, but there was no 
significant difference between the nanosilver mouth wash and the Chlorhexidine mouthwash. 
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INTRODUCTION 
Over a period of time it has been observed that the cost for the preservative dentistry is similar to and possibly 
less than the cost of introduction and replacing dental restorations. The early intervention concept is interesting 
as it may be easier to affect the caries-associated bacteria before their permanent colonization compared with 
later in life when the resident oral flora is firmly established.
1
  Dental caries in adults and children has a 
multifactorial etiology; therefore preventive measures usually involve a combination of dietary counseling, oral 
hygiene, and fluoride application.
1  
None of these interventions specifically target anaerobic periodontal 
pathogens the chief pathogens responsible for caries. An antibacterial agent that is effective and also acceptable 
to adults and children will be a useful supplement to current techniques for the prevention of caries.
2
  
Chlorhexidineis the antimicrobial agent most familiar to dental professionals for prevention of dental caries in 
adults and children.
3 
 The necessitate for frequent application of Chlorhexidine, and other side effects such as 
unlikable taste and staining, has encouraged the search for option that are more suitable for patients as nanosilver 
mouthwash. Silver (Ag) nanomaterials (nanosilver) are widely utilized today for their antibacterial activity. In 
medical care nanosilver has been used, for example, as an antibacterial agent in wound dressings,
4
 such as 
bandages to protect patients with severe burns against infections. It has also been used in catheters to prevent the 
formation of infectious biofilm.
5
 It can be anticipated that, with prices of medical applications of nanosilver 
decreasing, their use will increase. Nanosilver has also been used in consumer products such as sports textiles, 
other textiles, washing powder and deodorants, where nanosilver should reduce undesired odours. The last 10 
years review papers suggest that at the current level of exposure nanosilver may not be hazardous to humans and 
may result in low internal exposure.
6, 7, 8
  In this circumstance, a study was undertaken to ascertain the effects of 
a mouthwash prepared with  nanosilver on the dental plaque, gingival inflammation, and microbial counts in 
adults, and to compare the effect of it with commercially available Chlorhexidine mouthwash. 
MATERIALS AND METHODS 
This study was conducted at the Department of Oral Medicine and Periodontology, College of Dentistry, 
University of Sciences and Technology, in collaboration with the Department of Microbiology, Faculty of 
Medicine and Health Sciences University of Sciences and Technology. Approval from the University of 
Sciences and Technology Ethics Committee was obtained before initiating the study (MECA NO.: 2016/22). All 
patients signed an informed consent form.  
Study Design:  This study was a triple-blinded randomized controlled comparative trial of four weeks duration, 
conducted in the Dental Polyclinics of the Dental College at University of Science and Technology (UST), 
Sana’a, Yemen.  
  
Study Population: The sample of the present study consisted of patients with average age of 23 years referred 
for treatment to the Dental Polyclinics of the Dental College at UST. The subjects were enrolled between 
January and November 2017. The inclusion criteria of this study comprised good general health, availability for 
the 4 weeks duration of the study, patients who have evidence of plaque-induced gingivitis without periodontitis, 
and a minimum of 20 natural teeth, excluded third molars. Subjects were excluded from the study if they had any 
of the following conditions: orthodontic bands; partial removable dentures; pregnant or breast feeding women; 
subjects who had systemic disorders and/or undertake medication which might influence the periodontal; 
individuals with history of allergic to oral consumer products; smoking; patients who received periodontal 
treatment or antibiotic therapy any time during the one month prior to entry into the study; subjects who had 
tumor(s) or significant pathology in the soft or hard tissues of the oral cavity; five or more carious lesions 
needful immediate care; subjects received a dental prophylaxis in the past two weeks prior to the baseline 
examination.  
   After a screening examination that comprised a full medical and dental history and intraoral examination, the 
final sample size in the study consisted of 62 patients' with plaque-induced gingivitis (28 males and 34 females) 
according to the inclusion/exclusion criteria.  
The subjects were then randomly divided into two groups as shown in figure 1: The control group that 
consisted of 34 patients who rinsed with 0.12% chlorhexidine mouthwash (Shiba Pharma co., Yemen), 10ml for 
one minute twice daily. The experimental group included 34 patients who rinsed with a nanosilver mouthwash 
(Nanogist co., Korea), 10 ml for one minute twice daily. 
 Experimental Design: All patients received a complete dental prophylaxis to remove all plaque, calculus and 
extrinsic stain before entering the study.
9
  The participants were motivated on regular intervals by personal and 
phone contact, to use tooth brush and mouthwash on regular basis. The patients were instructed to use soft tooth 
brush, brush only with similar toothpaste 
9
 (Colgate® Cavity Protection fluoride toothpaste) and to brush their 
teeth twice daily, once in the morning after breakfast and once in the evening before bedtime. They were 
instructed to brush a minimum of 3 minutes to ensure thorough brushing. They also were informed about the 
same brushing technique (bass technique). They were instructed to rinse their mouth with mouth wash at least 
half an hour after tooth brushing and instructed not to take any liquid or food for at least 30 minutes after using 
mouth wash to avoid reduction the substantively of mouth wash, thus decreasing the efficacy of the mouth wash 
and to diminish the side effects of CHX like staining and bad taste.
10
 
   All mouth washes were wrapped by an assistant in opaque vials containing the codes A and B. The assistant 
added a new patient to a list of randomly assigned letters (A and B), and the patient was given the medication 
assigned that letter. Thus, this way the triple blinding of the examiner, the statistician and the subjects was 
achieved. The calibration performed for this step showed highly intra-examiner agreement (Kappa =0.90) was 
achieved. 
Sub-gingival Plaque Sampling: Plaque sample was taken at baseline, two weeks, and finally at four weeks. The 
quadrant teeth were primarily isolated using cotton wool rolls, the lingual surface of the teeth was dried with a 
gentle stream of air and a saliva ejector was used to maintain sampled area dry. The plaque samples were 
obtained by insertion of standardized #40 a sterile disposable paper point into the deepest part of periodontal 
sulcus from lingual surface of the tooth number 36 and 16 (the lower left 1st molar and upper right 1st molar) 
and left in situ for few seconds, pooled separately, placed in 5 ml tryptone soya broth sterile tubes and stored in a 
refrigerator at +4° until analysis. 
Sample Analysis: Plaque samples were put in tube contains 1 ml normal saline (0.9 % Nacl) then vortexed for 
30 seconds; next ten folds dilution was done to have 10
-2
 (100 fold) dilution to permit the colonies forming units 
countable. By 50 µL micropipette, the serial dilutions were cultured on blood agar media. The plates were 
incubated at 37°C for 48 hours. The anaerobic conditions were obtained by using simple anaerobic jar in 
conjunction with a standardized anaerobic procedure and using of anaerobic gas pack system. The number of 
bacteria in a culture was estimated by direct counting of the organisms, all colonies with different morphologies, 
colors, sizes and hemolytic reactions were selected and results were expressed as a colony forming units per 
sample (CFU / sample). CFU on each plate were counted manually. 
Statistical Analysis: The analysis of the data was performed using SPSS 21.0 for Windows (SPSS Inc., 
Chicago, IL, USA). The Mann-Whitney U-test was used to determine statistical significance of mean values 
between groups (intergroup analysis). The bacterial count (CFUs) within the groups was evaluated using the 
Wilcoxon signed rank test (intergroup analysis). The significance level was set at p < 0.05. 
RESULTS  
At the onset of the study, there were 68 participants. Six participants dropped out, 2 from NS group, and 4 from 
CHX group, thus at the end of the study, 62 participants were present (CHX=30, and NS=32). Dropping out was 
  
due to failure in following the study protocol. Intergroup comparison by Mann- Whitney U-test showed no 
statistically significant differences between the groups at baseline for all studied parameters. Table 1shows the 
antimicrobial effect of nanosilver mouth wash on the CFU of anaerobic plaque pathogens at different time of 
use.  It is very obvious that the values of CFU decreased significantly (p<0.001) as the time of use  nanosilver 
mouth  wash  until reaching the highest value when the time of use was 4 weeks. There was increase in the 
inhibition of growth with time of use in which the inhibition rates for 2 weeks used and for 4 weeks used were 
46% and 79.7% respectively. Also, there was decrease of Mean±SD of CFU as we proceed from A: zero time of 
nanosilver mouth wash use; B: 2 weeks, and C: 4 weeks [70.3±47 to 32.4±24.6 (2 weeks), and 14.2±9.9 (4 
weeks). In intergroup comparison CFU of the bacteria at each period of use nanosilver mouth wash was 
compared to the CFU at all the periods of use; there was a high significant statistical difference between the zero 
time (had no use) and the 4 weeks (p<0.001) (Table 1).  Table 2 shows the antimicrobial effect of 
chlorohexidene mouth wash on the CFU of anaerobic plaque pathogens at different time of use. It is very 
obvious that the values of CFU decreased significantly (p<0.001) as the time of use chlorohexidene mouth wash 
until reaching the highest value when the time of use was 4 weeks. There was increase in the inhibition of growth 
with time of use in which the inhibition rates for 2 weeks use and for 4 weeks use were 51.2% and 77% 
respectively. As well, there was decrease of Mean±SD of CFU as we proceed from A: zero time of 
chlorohexidene mouth wash use; B: 2 weeks, and C: 4 weeks [63.3±55.3 to 30.9±14.5 (2 weeks), and 14.5±11.1 
(4 weeks).  Table 3 shows the significance of the antimicrobial effect of nanosilver mouth wash on the mean 
±SD CFU of anaerobic plaque pathogens at different period of use. It is very obvious that the Mean  ±SD  of 
CFU decreased significantly as the time of use  nanosilver mouth  wash in which  the mean  ±SD at zero time  
70.3± 47, decreased to  32.4±24.6 after 2 weeks of use (P < 0.0001),  until reaching  14.2± 9.9 when the time of 
use was 4 weeks (0.0002).  Table 4 shows the significance of the antimicrobial effect of chlorohexidene mouth 
wash on the mean ±SD CFU of anaerobic plaque pathogens at different period of use. It is very obvious that the 
Mean  ±SD  of CFU decreased significantly as the time of use chlorohexidene mouth  wash in which  the mean  
±SD at zero time  63.3± 55.3  decreased to  30.6±26.5 after 2 weeks of use (P < 0.0043),  until reaching  
14.5±11.1 when the time of use was 4 weeks (<0.0001). Table 5 shows the Mean ±SD values of bacterial count 
of both NS and CHX groups. There is no statistically significant difference between NS and CHX groups for 
bacterial counts at 2 and 4 weeks follow up. The bacterial counts was lower in the NS group than that in CHX 
group, but there is no significant difference between them at the three experimental time points (p > 0.05). 
DISCUSSION 
Dental plaque has long been considered to be the main etiological agent in gingivitis and periodontal disease. 
Therefore, suitable plaque control is very vital to prevent the incidence of the abovementioned disease.
11
 The 
plaque control can be accomplished by mechanical, chemical, or by a combination of the both. Mouthwash 
which is a chemical plaque control should be used along with mechanical hygiene.
12,13
 It has been recommended 
being a regular adjunct along with mechanical therapy to maintain oral health.
14
 Among the available 
mouthwashes, CHX is considered to be the gold standard and is part of the periodontal treatment regimen.
10 
However, CHX is known to have various side effects ranging from minor effects such as alteration in patient 
taste sensation and staining of teeth to certain less common effects such as mucosal erosion or parotid 
swelling.
10,15,16
 Considering the adverse effects of the use of CHX, its use for long-term therapy has been limited 
or not actively recommended.
16
  Several mouthwashes without the similar negative effects as CHX have been 
tried for long-term therapy, but none has been successful in providing similar antiplaque and antigingivitis effect 
as CHX.
10,15,16
  NS mouthwash has gained attention for their antimicrobial properties.
17 
This is attributed to that 
NS products has small size properties (nanoparticles), which they have potential to penetrate the microorganisms 
and destroy them. Thus, the present study was conducted to compare the effects of NS and CHX on treatment of 
patients with plaque-induced gingivitis using bacterial counts.  Various methods have been used to investigate 
the equivalence of the mouthwash in killing the bacteria, including polymerase chain reaction (PCR), culture 
procedures, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC).
18-20
  
   In the current study , It was very obvious that the values of CFU decreased significantly (p<0.001) as the time 
of use  nanosilver mouth  wash  until reaching the highest value when the time of use was 4 weeks (table 1). The 
antibacterial effects of  NS in the current study is in agreement with a study conducted by Halkai et al.
21
 who 
found that NS revealed effective antibacterial ability against P. gingivalis, also with numerous studies that 
demonstrated; reduction of microbial infections after use of NS.
22-25
 
In the current study; also the bacterial counts was lower in the NS group than in CHX group, but there was no 
significant difference between them at the three experimental time points (p > 0.05). (Table 5).  In contrast to the 
current study Esfahanian et al. 
26
 showed that CHX mouthwash had a significant statistical superiority in 
comparison with the NS mouthwash in antimicrobial activity.  Additionally, Ahrari et al. 
20
 also found that the 
NS produced antibacterial effects significantly lower than that of the 0.2% CHX mouthwash. The difference 
between the current study result and previous studies could be due to that they tested the different effect in vitro 
  
conditions. However, the current study results is different from  positive result for NS over CHX that reported by 
 Kariminik et al. 
27
 which showed that NS mouthwash was more effective than CHX in killing bacteria. These 
differences from the present study might be attributed to that the bacterial samples were taken from saliva, not 
dental plaque as in the current study.  Basins et al.
28
 showed that NS had the strongest antibacterial activity of 
the NPs tested, with bacterial growth lower than that in CHX. Mozayeni et al.
29
 indicated that NS gel were 
significantly had less effect than that of CHX gel against C. albicans.  
As a final point ,there are limitations in the current study that should be considered,  The number of plaque-
induced gingivitis persons studied was lower; further study with a larger sample size number should be 
performed to confirm the results. Lastly, the follow-up period was only 4 weeks; further study with a long 
follow-up period should be take into account. 
CONCLUSION 
Within the limitations of the present study, it can be concluded that the NS and CHX mouthwashes reduced 
bacterial counts in patients with plaque-induced gingivitis roughly in equal effect. This study confirmed the anti-
microbial activities of  NS. Also, NS is considered as an antimicrobial alternative to the CHX as mouthwash 
suitable for plaque control. 
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Figure 1: Experimental Design  
Table 1: The antimicrobial effect of nanosilver mouth wash on the CFU of anaerobic plaque pathogens at 
different time of use.  
 
CFU Values  Time of uses (week) 
Zero A 2 weeks B 4 weeks C 
Mean 70.3 32.4 14.2 
Variance 2299 606 98 
Standard division 47 24.6 9.9 
Standard error 8.6 4.4 1.7 
Min 8 5 0 
Max 216 115 40 
Median 76 30 12 
Mode 77 38 7 
Sum 2181 1005 442 
student test 8.1 7.3 8.1 
P value <0.001 <0.001 <0.001 




Table 2: The antimicrobial effect of chlorohexidene mouth wash on the CFU of anaerobic plaque pathogens at 
different time of use. 
CFU Values  Time of uses (week) 
Zero 2 weeks 4 weeks 
Mean 63.3 30.9 14.5 
Variance 3063 70.4 123 
Standard division 55.3 26.5 11.1 
Standard error 9.9 4.7 1.9 
Min 10 5 1 
Max 300 138 43 
Median 48 22 11 
Mode 40 20 7 
Sum 1964 959 451 
Significant of variation 
(student test) 
6.3 6.4 7.2 
P value <0.001 <0.001 <0.001 







Table 3: The significance of the antimicrobial effect of nanosilver mouth wash on the mean ±SD CFU of 
anaerobic plaque pathogens  at different period of use. 
 
Time of Use (week) CFU of anaerobic plaque pathogens  
Mean  ±SD P value 
Zero (baseline) 70.3± 47 Reference 
2 weeks 32.4±24.6 P = 0.0002 
4 weeks 14.2± 9.9 P < 0.0001 
 
P-value, is calculated using the t-test  
 
 
Table 4: The significance of the antimicrobial effect of chlorohexidene mouth wash on the mean ±SD CFU of 
anaerobic plaque pathogens at different period of use 
 
Time of use (week) CFU anaerobic plaque pathogens  bacteria 
Mean±SD P value 
Zero (baseline)Ref 63.3 ± 55.3 Reference 
2 weeks 30.6± 26.5  0.0043 
 
4 weeks 14.5±11.1  < 0.0001 
 
 P-value, is calculated using the t-test  
 
Table 5:  Comparison of  antimicrobial effect of nanosilver mouth-wash  with of chlorohexidene mouth wash on 
 CFU of anaerobic plaque pathogens  
Time of Use (week) nanosilver mouth-wash   chlorohexidene mouth 
wash 
P value 
Mean  ±SD Mean  ±SD 
Zero (baseline) 70.3± 47 63.3 ± 55.3 NS  
2 weeks 32.4±24.6 30.6± 26.5 NS 
4 weeks 14.2± 9.9 14.5±11.1* NS 
 
NS > 0.05, P-value, is calculated using the t-test  
 
 
 
